Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new publication citation related to NODE-303 was added to the Publications section, describing a post hoc analysis of self-administered etripamil nasal spray in atrial fibrillation.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check53 days agoChange DetectedUI and metadata updates include adding a Show glossary option, adding Last Update Submitted that Met QC Criteria, standardizing 'No FEAR Act Data' capitalization, and updating the revision label to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.